Age-related increase in CNS sensitivity to benzodiazepines as assessed by task difficulty
- PMID: 1967500
- DOI: 10.1007/BF02245796
Age-related increase in CNS sensitivity to benzodiazepines as assessed by task difficulty
Abstract
The differential sensitivity of young and elderly healthy adults to the impairment effects of benzodiazepines was assessed by tasks with several levels of difficulty. Using a double-blind procedure, single doses of placebo, alprazolam (0.75 and 1.5 mg) and triazolam (0.25 and 0.5 mg) were ingested orally by 10 young men, 9 young women, 7 elderly men, and 10 elderly women. Order of drug administration was determined by a random Latin square design. Different versions of the subcritical tracking and digit symbol substitution tasks were characterized by three difficulty levels. Assessments of task performance were conducted at varying intervals for 7 h after drug administration. Both drugs induced a rapid initial onset of impairment in the two age groups. Evidence of increased drug sensitivity in the elderly was provided by the more prolonged duration of the pharmacologic effect in the older than young subjects, especially for the harder versions of the SCT and DSS tasks. In summary, the data provide support for the hypothesis of an age-related decline in the adaptive capacity to inhibit adverse drug effects.
Similar articles
-
Comparison of the effects of quazepam and triazolam on cognitive-neuromotor performance.Psychopharmacology (Berl). 1987;92(4):459-64. doi: 10.1007/BF00176478. Psychopharmacology (Berl). 1987. PMID: 2888152 Clinical Trial.
-
Increased sensitivity to alprazolam in females with a paternal history of alcoholism.Psychopharmacology (Berl). 2000 Jun;150(2):150-62. doi: 10.1007/s002130000421. Psychopharmacology (Berl). 2000. PMID: 10907668 Clinical Trial.
-
Sensitivity to triazolam in the elderly.N Engl J Med. 1991 Jun 13;324(24):1691-8. doi: 10.1056/NEJM199106133242403. N Engl J Med. 1991. PMID: 2034245 Clinical Trial.
-
Pharmacokinetic and pharmacodynamic consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam.J Clin Pharmacol. 1999 Nov;39(11):1109-25. J Clin Pharmacol. 1999. PMID: 10579141 Review.
-
Benzodiazepines and vigilance performance: a review.Psychopharmacology (Berl). 1989;98(2):145-56. doi: 10.1007/BF00444684. Psychopharmacology (Berl). 1989. PMID: 2569213 Review.
Cited by
-
Adverse performance effects of acute lorazepam administration in elderly long-term users: pharmacokinetic and clinical predictors.Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jan 2;56:129-35. doi: 10.1016/j.pnpbp.2014.08.014. Epub 2014 Sep 6. Prog Neuropsychopharmacol Biol Psychiatry. 2015. PMID: 25195839 Free PMC article.
-
Saliva Lipids May Determine Alprazolam Toxicity: An FTIR Study.Iran J Pharm Res. 2024 Aug 20;23(1):e146675. doi: 10.5812/ijpr-146675. eCollection 2024 Jan-Dec. Iran J Pharm Res. 2024. PMID: 39895672 Free PMC article.
-
The interactive walkway provides fit-for-purpose fall-risk biomarkers in the elderly: Comparison of zolpidem and suvorexant.Clin Transl Sci. 2024 Jul;17(7):e13875. doi: 10.1111/cts.13875. Clin Transl Sci. 2024. PMID: 38978326 Free PMC article. Clinical Trial.
-
Biomarkers for the effects of benzodiazepines in healthy volunteers.Br J Clin Pharmacol. 2003 Jan;55(1):39-50. doi: 10.1046/j.1365-2125.2002.t01-10-01714.x. Br J Clin Pharmacol. 2003. PMID: 12534639 Free PMC article. Review.
-
Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).Clin Pharmacokinet. 1991 Oct;21(4):262-73. doi: 10.2165/00003088-199121040-00003. Clin Pharmacokinet. 1991. PMID: 1684744 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical